Milestone Pharmaceuticals
Montréal
About Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases. Milestone's lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as atrial arrhythmias and angina.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Total funding: $360.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2025)
- Ticker: nasdaq:MIST
- Website: milestonepharma.com
- Phone: (514) 336-0444
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/milestone-pharmaceuticals-149681 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.